Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Mainz Biomed B.V.
Mainz Biomed B.V. News
Mainz Biomed B.V. Quantitative Score
About Mainz Biomed B.V.
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
Mainz Biomed B.V. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
Mainz Biomed B.V. Financials
Table Compare
Compare MYNZ metrics with: | |||
|---|---|---|---|
Earnings & Growth | MYNZ | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | MYNZ | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | MYNZ | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | MYNZ | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Mainz Biomed B.V. Income
Mainz Biomed B.V. Balance Sheet
Mainz Biomed B.V. Cash Flow
Mainz Biomed B.V. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Sell |
| Return on Equity | Strong Sell |
| Return on Assets | Strong Sell |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Buy |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Historical Market Cap
Shares Outstanding
Mainz Biomed B.V. Executives
| Name | Role |
|---|---|
| Christopher Von Toerne | Chief Operating Officer |
| Guido Baechler | Chief Executive Officer & Executive Director |
| Stefan Erlach | Head of Human Resources |
| William J. Caragol | Chief Financial Officer & Senior Vice President |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Christopher Von Toerne | Chief Operating Officer | 1972 | -- | |
| Guido Baechler | Chief Executive Officer & Executive Director | Male | 1965 | -- |
| Stefan Erlach | Head of Human Resources | Male | -- | |
| William J. Caragol | Chief Financial Officer & Senior Vice President | Male | 1967 | -- |